Digital MSK company SWORD health tapped Valentina Longo to serve as its next chief financial officer. 

This comes months after the company announced a $163 million Series D funding round, bringing its total valuation to $2 billion. 

Longo is coming to SWORD from the Financial Institutions Group at Cerbeus, where she served as the managing director. Her experience also includes time as the CFO at Partner Card business at JP Morgan Chase. 

“SWORD’s mission deeply resonated with my personal experience and how important it is for a family to have access to high quality Physical Health care. I am thrilled to join this world class innovative company that is disrupting the health sector on a global level. I am looking forward to working with Virgilio and the rest of the organization,” Longo said.

Metabolic health startup Calibrate announced a slew of new hires. Dave Fielding, former head of finance at Verily Health, will join as chief financial officer. 

The company hired Scott Honken as its next chief commercial officer. Honken previously served as CCO at Rightway and VP of Strategic Partnership at Livongo. 

Calibrate named Kim Stephan its new general counsel. She is coming from Virgin Pulse, where she served as general counsel and head of people. 

“There has never been a more exciting moment at Calibrate and I am thrilled to bring on this all-star talent at such a pivotal moment for the business,” Isabelle Kenyon, CEO and founder of Calibrate, said in a statement.

“Scott has overseen growth for some of digital health’s darlings, including Livongo, and Dave has guided major high-growth healthcare brands to finance health, and Kim is simply the best in the business as a legal mastermind. Together, these new and talented individuals bring decades of expertise that will help us rapidly grow Calibrate and fulfill our mission to change the way the world treats weight.”

These new hires come less than a year after the virtual weight loss company raised $100 million in Series B funding.

RecoveryOne, a virtual MSK company, announced Dustin Armitage and Matt Cervi will be joining the team as sales leaders. 

Armitage has worked with a number of digital health companies, including Sapphire Digital, Welltok and Ovia Health. Cervi is joining the team after working at diabetes-focused company DayTwo.

“With the massive increase in demand for virtual MSK solutions, we continue to expand our team to further empower more individuals with access to a lower cost, clinically-validated solution,” Brian Harrigan, EVP, employer sales and client success of RecoveryOne, said in a statement.

“The addition of tenured sales talent will enhance our efforts to ensure employees gain access to RecoveryOne’s solution via their employers, thereby providing them with the ability to recover from pain affordably, and on their schedule. In turn, we hope to see a reduction in absenteeism and an increase in recovery.”

In September the company announced a $33 million Series C funding round.

Half a year after online pharmacy NowRx closed a $73 million Series C funding round, the company is getting a new CFO. The Mountain View, California-based startup named Mark Marlow its next CFO. Marlow previously served as a managing partner at Omphalos Venture Partners, and as CFO and cofounder at Virtual Radiologic Corp. 

“The company is growing quickly, expanding both its geographic reach and the services it offers,” Mark Marlow said in a statement. “And it has been able to do that while still earning five-star reviews from customers. NowRx is out in front of the competition with its focus on improving the collaboration between three parties: physician, pharmacist and patient. Legacy players just don’t have the business model or technology to catch up. I’m excited to join the team and help accelerate its progress.”